Rare Dominant β-Thalassemia Mutation, Codon 121 (GAA>TAA) (HBB:c.364G>T): Case Report of a Ukrainian Family

Background: Dominant β-thalassemia is a rare disorder caused by highly unstable β-globin variants that result in ineffective erythropoiesis and variable clinical phenotypes. Codon 121 lies within a functionally important region of the β-globin chain, and mutations at this site are exceptionally rare. The HBB:c.364G>T (GAA>TAA) variant introduces a premature stop codon, leading to production of a truncated β-globin chain. We describe the clinical, hematological, and molecular findings of a Ukrainian family carrying this previously reported rare variant, with particular emphasis on intrafamilial phenotypic variability. Case report presentation: Clinical history, hematological parameters, and molecular findings were evaluated in four affected individuals from three generations of the same family. Genetic analysis identified the heterozygous nonsense mutation HBB:c.364G>T (codon 121, GAA>TAA) in all affected members with variable clinical severity. Two adults had previously undergone splenectomy, whereas two pediatric patients remain under clinical follow-up. A history of premature death in another affected relative suggests the potential for severe disease-related complications. All patients had microcytic hypochromic anemia with elevated HbA2 levels. Adult carriers demonstrated anisopoikilocytosis, circulating erythroblasts, and Howell–Jolly bodies. Compared with the adults, pediatric patients exhibited lower hemoglobin levels and higher HbF levels, consistent with age-related hematologic differences and physiological persistence of fetal hemoglobin. Conclusions: This report provides additional clinical and molecular characterization of the rare HBB:c.364G>T variant and highlights the phenotypic variability observed among affected members of the same family. These findings emphasize the importance of molecular confirmation and careful clinical assessment in patients with suspected dominant β-thalassemia.

Authors

Institutions

Publication Details

Journal
Thalassemia Reports
Published
2026-11-18
DOI
https://doi.org/10.3390/thalassrep16040026
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rare Dominant β-Thalassemia Mutation, Codon 121 (GAA>TAA) (HBB:c.364G>T): Case Report of a Ukrainian Family

Eleni Yfanti, Evangelia-Eleni Delaki, Theodora Maria Venou, Stamatia Theodoridou et al.
3 links
Thalassemia Reports
Hemoglobinopathies and Related Disorders
article

Rare Dominant β-Thalassemia Mutation, Codon 121 (GAA>TAA) (HBB:c.364G>T): Case Report of a Ukrainian Family

Eleni Yfanti, Evangelia-Eleni Delaki, Theodora Maria Venou, Stamatia Theodoridou, Efthymia Vlachaki, Genovefa Mantzou, Maria Dimopoulou, Evangelia Zarkada, Haralambia Avgerinou
article en

Abstract

Background: Dominant β-thalassemia is a rare disorder caused by highly unstable β-globin variants that result in ineffective erythropoiesis and variable clinical phenotypes. Codon 121 lies within a functionally important region of the β-globin chain, and mutations at this site are exceptionally rare. The HBB:c.364G>T (GAA>TAA) variant introduces a premature stop codon, leading to production of a truncated β-globin chain. We describe the clinical, hematological, and molecular findings of a Ukrainian family carrying this previously reported rare variant, with particular emphasis on intrafamilial phenotypic variability. Case report presentation: Clinical history, hematological parameters, and molecular findings were evaluated in four affected individuals from three generations of the same family. Genetic analysis identified the heterozygous nonsense mutation HBB:c.364G>T (codon 121, GAA>TAA) in all affected members with variable clinical severity. Two adults had previously undergone splenectomy, whereas two pediatric patients remain under clinical follow-up. A history of premature death in another affected relative suggests the potential for severe disease-related complications. All patients had microcytic hypochromic anemia with elevated HbA2 levels. Adult carriers demonstrated anisopoikilocytosis, circulating erythroblasts, and Howell–Jolly bodies. Compared with the adults, pediatric patients exhibited lower hemoglobin levels and higher HbF levels, consistent with age-related hematologic differences and physiological persistence of fetal hemoglobin. Conclusions: This report provides additional clinical and molecular characterization of the rare HBB:c.364G>T variant and highlights the phenotypic variability observed among affected members of the same family. These findings emphasize the importance of molecular confirmation and careful clinical assessment in patients with suspected dominant β-thalassemia.

Thalassemia ReportsVol. 16(4)
Laiko General Hospital of Athens (GR), Ippokrateio General Hospital of Thessaloniki (GR), Hippocration General Hospital (GR)
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon